Apparent Lack Of Pharmacological Effect Of Steviol Glycosides Used As Sweeteners In Humans. A Pilot Study Of Repeated Exposures In Some Normotensive And Hypotensive Individuals And In Type 1 And Type 2 Diabetics
|Trial Design||Double blind|
|Trial Length||1-6 months|
|Number of Subjects||72|
|Age Range||18-29, 30-44, 45-64|
|Body Types||Overweight, Average|
No significant effects of 750mg steviosides daily for 3 months aside from a small reduction in blood pressure and glucose seen in the type 1 diabetic cohort.